Form 4/A for SUPN SUPERNUS PHARMACEUTICALS, INC.
Accepted 2023-01-13 00:00:00 ET · period of report 2022-03-14 · accession 0001104659-23-003861 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DA | 2023-01-13 | 2022-03-14 | SUPN | Khattar Jack A. | Pres, CEO, Dir | A - Grant | $0.00 | +20.0K | 576.5K | +4% | $0 |
| DA | 2023-01-13 | 2022-03-14 | SUPN | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $0.00 | +40.0K | 556.5K | +8% | $0 |
| DA | 2023-01-13 | 2022-03-14 | SUPN | Khattar Jack A. | Pres, CEO, Dir | M - OptEx | $0.00 | -40.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-14 | A | A | 20,000 | $0.00 | 576,466 | D | — | — | (F1) Shares of common stock received upon the settlement of certain performance share units granted to the Reporting Person on February 19, 2021. |
| 2 | Common | Common Stock | 2022-03-14 | M | A | 40,000 | $0.00 | 556,466 | D | — | — | (F1) Shares of common stock received upon the settlement of certain performance share units granted to the Reporting Person on February 19, 2021. |
| 3 | Derivative | Performance Share Unit | 2022-03-14 | M | D | 40,000 | $0.00 | 0 | D | $0.00 · — to 2031-02-19 | 40,000 Common Stock | (F3) On February 19, 2021, the Reporting Person was awarded Performance Shares Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period. |